Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Human Molecular Genetics

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDM367PMID 18065780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential Proteomics Analysis of Synaptic Proteins Identifies Potential Cellular Targets and Protein Mediators of Synaptic Neuroprotection Conferred by the Slow Wallerian Degeneration (Wlds) Gene*S

  2007cited by this paper
• A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle

  2007cited by this paper
• Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1.

  2007cited by this paper
• Calcium and neurodegeneration

  2007cited by this paper
• Transcriptional Induction of Mammalian ER Quality Control Proteins Is Mediated by Single or Combined Action of ATF6α and XBP1

  2007cited by this paper
• ER stress and diseases

  2007cited by this paper
• Nucleobindin 1 Controls the Unfolded Protein Response by Inhibiting ATF6 Activation*

  2007cited by this paper
• Signal integration in the endoplasmic reticulum unfolded protein response

  2007cited by this paper
• Motor Neuron Disease-Associated Mutant Vesicle-Associated Membrane Protein-Associated Protein (VAP) B Recruits Wild-Type VAPs into Endoplasmic Reticulum-Derived Tubular Aggregates

  2007influential reference
• Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis.

  2007cited by this paper
• Genetics of sporadic amyotrophic lateral sclerosis.

  2007cited by this paper
• The yeast VAP homolog Scs2p has a phosphoinositide-binding ability that is correlated with its activity.

  2007cited by this paper
• Transmembrane bZIP Transcription Factors in ER Stress Signaling and the Unfolded Protein Response

  2007cited by this paper
• Efficient Trafficking of Ceramide from the Endoplasmic Reticulum to the Golgi Apparatus Requires a VAMP-associated Protein-interacting FFAT Motif of CERT*

  2006cited by this paper
• Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model.

  2006cited by this paper
• Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion.

  2006cited by this paper
• Expanding the phenotypes of the Pro56Ser VAPB mutation: Proximal SMA with dysautonomia

  2006cited by this paper
• Synaptic Vulnerability in Neurodegenerative Disease

  2006cited by this paper
• The neuroprotective Wld S gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells

  2006cited by this paper
• Characterization of Amyotrophic Lateral Sclerosis-linked P56S Mutation of Vesicle-associated Membrane Protein-associated Protein B (VAPB/ALS8)*

  2006influential reference
• The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells.

  2006cited by this paper
• Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF

  2006cited by this paper
• Spinal muscular atrophy: from gene to therapy.

  2006cited by this paper
• A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis

  2005cited by this paper
• Expression of FKBP12 and ryanodine receptors (RyRs) in the spinal cord of MND patients

  2005cited by this paper
• Differential Regulation of Endoplasmic Reticulum Structure through VAP-Nir Protein Interaction*

  2005cited by this paper
• Genetic Interactions Due to Constitutive and Inducible Gene Regulation Mediated by the Unfolded Protein Response in C. elegans

  2005cited by this paper
• Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.

  2005cited by this paper
• Structural basis of FFAT motif-mediated ER targeting.

  2005cited by this paper
• Hepatitis C virus non-structural protein NS4B can modulate an unfolded protein response.

  2005cited by this paper
• SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN.

  2005cited by this paper
• Progressive loss of motor neuron function in wasted mice: effects of a spontaneous null mutation in the gene for the eEF1 A2 translation factor.

  2005cited by this paper
• A Highly Conserved Binding Site in Vesicle-associated Membrane Protein-associated Protein (VAP) for the FFAT Motif of Lipid-binding Proteins*

  2005cited by this paper
• Human VAP-B Is Involved in Hepatitis C Virus Replication through Interaction with NS5A and NS5B

  2005cited by this paper
• Natural history of denervation in SMA: Relation to age, SMN2 copy number, and function

  2005cited by this paper
• Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study

  2005cited by this paper
• Stable Binding of ATF6 to BiP in the Endoplasmic Reticulum Stress Response

  2005cited by this paper
• Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus.

  2004cited by this paper
• CHOLESTEROL HOMEOSTASIS FAILURE : A UNIFYING CAUSE OF SYNAPTIC DEGENERATION

  2004cited by this paper
• Progressive and selective degeneration of motoneurons in a mouse model of SMA

  2004cited by this paper
• Gene Recruitment of the Activated INO1 Locus to the Nuclear Membrane

  2004cited by this paper
• A novel locus for late onset amyotrophic lateral sclerosis/motor neurone disease variant at 20q13

  2004influential reference
• Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

  2004cited by this paper
• A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis.

  2004cited by this paper
• Interactions between Viral Nonstructural Proteins and Host Protein hVAP-33 Mediate the Formation of Hepatitis C Virus RNA Replication Complex on Lipid Raft

  2004cited by this paper
• A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy

  2003influential reference
• A conserved ER targeting motif in three families of lipid binding proteins and in Opi1p binds VAP

  2003cited by this paper
• Neuromuscular defects in a Drosophila survival motor neuron gene mutant.

  2003cited by this paper
• The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: Insights from WldS and other mutant mice

  2003cited by this paper
• Molecular pathways of endoplasmic reticulum dysfunctions: possible cause of cell death in the nervous system.

  2003cited by this paper
• Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology.

  2003cited by this paper
• Ultrastructural correlates of synapse withdrawal at axotomized neuromuscular junctions in mutant and transgenic mice expressing the Wld gene

  2003cited by this paper
• Smn, the spinal muscular atrophy–determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons

  2003cited by this paper
• Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner.

  2002cited by this paper
• Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development.

  2002cited by this paper
• Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model.

  2002influential reference
• An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles.

  2002influential reference
• ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals.

  2002cited by this paper
• Detection and visualization of protein interactions with protein fragment complementation assays.

  2002influential reference
• Vesicle-associated Membrane Protein-associated Protein-A (VAP-A) Interacts with the Oxysterol-binding Protein to Modify Export from the Endoplasmic Reticulum*

  2002cited by this paper
• Hepatitis C Virus Subgenomic Replicons Induce Endoplasmic Reticulum Stress Activating an Intracellular Signaling Pathway

  2002influential reference
• Compartmental neurodegeneration and synaptic plasticity in the Wlds mutant mouse

  2001cited by this paper
• VAP-A binds promiscuously to both v- and tSNAREs.

  2001cited by this paper
• Spinal Muscular Atrophy

  2001cited by this paper
• Deletion of Murine SMN Exon 7 Directed to Skeletal Muscle Leads to Severe Muscular Dystrophy

  2001cited by this paper
• Endoplasmic reticulum dysfunction – a common denominator for cell injury in acute and degenerative diseases of the brain?

  2001cited by this paper
• ATF6 Activated by Proteolysis Binds in the Presence of NF-Y (CBF) Directly to the cis-Acting Element Responsible for the Mammalian Unfolded Protein Response

  2000cited by this paper
• Early and Selective Loss of Neuromuscular Synapse Subtypes with Low Sprouting Competence in Motoneuron Diseases

  2000cited by this paper
• Fiber types in the mouse levator auris longus muscle: A convenient preparation to study muscle and nerve plasticity

  2000cited by this paper
• ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs.

  2000cited by this paper
• Motor neuron disease: Classification and nomenclature

  2000cited by this paper
• Mouse VAP33 is associated with the endoplasmic reticulum and microtubules.

  2000influential reference
• Activation of ATF6 and an ATF6 DNA binding site by the endoplasmic reticulum stress response.

  2000influential reference
• The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.

  2000cited by this paper
• Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP.

  2000cited by this paper
• Expression and distribution of the type 1 and type 3 inositol 1,4, 5-trisphosphate receptor in developing vascular smooth muscle.

  1999cited by this paper
• Erg30, a Vap-33–Related Protein, Functions in Protein Transport Mediated by Copi Vesicles

  1999influential reference
• Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress.

  1999cited by this paper
• Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins.

  1999influential reference
• Very severe spinal muscular atrophy (SMA type 0): an expanding clinical phenotype.

  1999cited by this paper
• Identification of a human homologue of the vesicle-associated membrane protein (VAMP)-associated protein of 33 kDa (VAP-33): a broadly expressed protein that binds to VAMP.

  1998cited by this paper
• Identification of the cis-Acting Endoplasmic Reticulum Stress Response Element Responsible for Transcriptional Induction of Mammalian Glucose-regulated Proteins

  1998cited by this paper
• The Saccharomyces cerevisiae SCS2 Gene Product, a Homolog of a Synaptobrevin-Associated Protein, Is an Integral Membrane Protein of the Endoplasmic Reticulum and Is Required for Inositol Metabolism

  1998cited by this paper
• Localization of ryanodine receptors in smooth muscle.

  1998cited by this paper
• The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease.

  1996cited by this paper
• A VAMP-binding protein from Aplysia required for neurotransmitter release.

  1995cited by this paper
• Expression of developmentally regulated cytoskeleton and cell surface proteins in childhood spinal muscular atrophies.

  1995cited by this paper
• Overview of motor neuron disease: classification and nomenclature.

  1995cited by this paper
• Identification and characterization of a spinal muscular atrophy-determining gene

  1995cited by this paper
• Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers.

  1989cited by this paper
• A unique cytoskeleton associated with crawling in the amoeboid sperm of the nematode, Ascaris suum

  1989cited by this paper
• The levator auris longus muscle of the mouse: a convenient preparation for studies of short- and long-term presynaptic effects of drugs or toxins.

  1987cited by this paper
• Modes and Mechanisms of Microbial Growth Inhibitors

  1983cited by this paper
• Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.

  1978cited by this paper
• On the degeneration of rat neuromuscular junctions after nerve section

  1970cited by this paper
• Brain

  1878cited by this paper

• Nusinersen rescues taurine deficiency in patients with type 1 Spinal Muscular Atrophy.

  2026cites this paper
• Organ-specific redox imbalances in spinal muscular atrophy mice are partially rescued by SMN antisense oligonucleotides.

  2026cites this paper
• Non-Cell-Autonomous Mechanisms and Systemic Interactions in Spinal Muscular Atrophy.

  2026cites this paper
• Examination of the Peripheral Nervous System in Children With Spinal Muscular Atrophy: A High‐Resolution Ultrasonographic Study

  2026cites this paper
• Skeletal muscle in spinal muscular atrophy: Critical insights from pathogenesis to therapeutic strategies.

  2026cites this paper
• Integrating Postsynaptic Morphology and Dynamics to Evaluate Neuromuscular Synapse Status: Insights from α-bungarotoxin.

  2025cites this paper
• Epigenetic Mechanisms Shaping Spine Regulation: Unveiling the Role of Cytoskeletal Dynamics and Localized Protein Synthesis

  2025cites this paper
• Munc13-1 restoration mitigates presynaptic pathology in spinal muscular atrophy

  2025cites this paper
• Loss of synaptic Munc13-1 underlies neurotransmission abnormalities in spinal muscular atrophy

  2025cites this paper
• Dissection and Whole-Mount Immunofluorescent Staining of Mouse Hind Paw Muscles for Neuromuscular Junction Analysis

  2025cites this paper
• Salbutamol in 5q spinal muscular atrophy: a systematic review and meta-analysis of efficacy and safety

  2025cites this paper
• Identifying novel response markers for spinal muscular atrophy revealed by targeted proteomics following gene therapy.

  2025cites this paper
• Phosphoglycerate kinase 1 as a therapeutic target in neurological disease.

  2025cites this paper
• Motor Unit Patterns Correlate With Severity in Symptomatic Patients With Spinal Muscular Atrophy

  2025cites this paper
• Cerebellar defects are a primary pathology in mouse models of spinal muscular atrophy

  2025influential citation
• Structural Proteins at Neuromuscular Junction Are Downgraded While NRG1 and Agrin Gene Expression Increases After Muscle Injury

  2025cites this paper
• Whole-body muscle MRI in patients with spinal muscular atrophy

  2025cites this paper
• Nusinersen corrects L-arginine deficiency in the cerebrospinal fluid of patients with severe spinal muscular atrophy.

  2025cites this paper
• Peripheral defects precede neuromuscular pathology in the Smn2B/− mouse model of spinal muscular atrophy

  2024cites this paper
• Improved gene therapy for spinal muscular atrophy in mice using codon-optimized hSMN1 transgene and hSMN1 gene-derived promotor

  2024cites this paper
• The Role of Brain Plasticity in Neuromuscular Disorders: Current Knowledge and Future Prospects

  2024cites this paper
• Why should a 5q spinal muscular atrophy neonatal screening program be started?

  2024cites this paper
• Severe dynein dysfunction in cholinergic neurons exacerbates ALS-like phenotypes in a new mouse model.

  2024cites this paper
• Beyond Motor Neurons in Spinal Muscular Atrophy: A Focus on Neuromuscular Junction

  2024cites this paper
• Disruption of Neuromuscular Junction Following Spinal Cord Injury and Motor Neuron Diseases

  2024cites this paper
• Liver SMN restoration rescues the Smn2B/- mouse model of spinal muscular atrophy

  2024cites this paper
• Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges

  2024cites this paper
• SMN Deficiency Induces an Early Non-Atrophic Myopathy with Alterations in the Contractile and Excitatory Coupling Machinery of Skeletal Myofibers in the SMN∆7 Mouse Model of Spinal Muscular Atrophy

  2024cites this paper
• The SMN Complex at the Crossroad between RNA Metabolism and Neurodegeneration

  2023cites this paper
• Mitigating aberrant Cdk5 activation alleviates mitochondrial defects and motor neuron disease symptoms in spinal muscular atrophy

  2023cites this paper
• Human Motor Endplate Survival after Chronic Peripheral Nerve Injury

  2023cites this paper
• Efficient generation of a self-organizing neuromuscular junction model from human pluripotent stem cells

  2023cites this paper
• Muscle: an independent contributor to the neuromuscular spinal muscular atrophy disease phenotype

  2023cites this paper
• Biomarkers in 5q-associated spinal muscular atrophy—a narrative review

  2023cites this paper
• Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7

  2023cites this paper
• A spinal muscular atrophy modifier implicates the SMN protein in SNARE complex assembly at neuromuscular synapses.

  2023cites this paper
• Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling in spinal muscular atrophy and amyotrophic lateral sclerosis.

  2023cites this paper
• Innovating spinal muscular atrophy models in the therapeutic era

  2023cites this paper
• Potentiation of neuromuscular transmission by a small molecule calcium channel gating modifier improves motor function in a severe spinal muscular atrophy mouse model.

  2023cites this paper
• Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy

  2022cites this paper
• Differential effect of Fas activation on spinal muscular atrophy motoneuron death and induction of axonal growth

  2022cites this paper
• Diminished motor neuron activity driven by abnormal astrocytic GLAST glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery

  2022cites this paper
• Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets

  2022cites this paper
• Bap1/SMN axis in Dpp4+ skeletal muscle mesenchymal cells regulates the neuromuscular system

  2022cites this paper
• A combinatorial approach increases SMN level in SMA model mice.

  2022cites this paper
• Motor Unit and Capillary Recruitment During Fatiguing Arm-Cycling Exercise in Spinal Muscular Atrophy Types 3 and 4

  2022cites this paper
• Neuromuscular denervation and deafferentation but not motor neuron death are disease features in the Smn2B/- mouse model of SMA

  2022cites this paper
• Functional regeneration of the murine neuromuscular synapse relies on long-lasting morphological adaptations

  2022cites this paper
• Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4

  2022influential citation
• DOK7 Promotes NMJ Regeneration After Nerve Injury

  2022cites this paper
• Modeling neuromuscular diseases in zebrafish

  2022cites this paper
• SMN Is Physiologically Downregulated at Wild-Type Motor Nerve Terminals but Aggregates Together with Neurofilaments in SMA Mouse Models

  2022cites this paper
• Spinal muscular atrophy

  2022cites this paper
• Mouse models of SMA show divergent patterns of neuronal vulnerability and resilience

  2022influential citation
• Combinatorial ASO-mediated therapy with low dose SMN and the protective modifier Chp1 is not sufficient to ameliorate SMA pathology hallmarks.

  2022cites this paper
• Editorial: Peripheral nerve anatomy in health and disease

  2022cites this paper
• Central and peripheral delivered AAV9-SMN are both efficient but target different pathomechanisms in a mouse model of spinal muscular atrophy

  2022cites this paper
• Premature delivery in the domestic sow in response to in utero delivery of AAV9 to fetal piglets

  2021cites this paper
• Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models

  2021cites this paper
• Central and peripheral delivery of AAV9-SMN target different pathomechanisms in a mouse model of spinal muscular atrophy

  2021cites this paper
• Functional Genomics of Axons and Synapses to Understand Neurodegenerative Diseases

  2021cites this paper
• Postsynaptic cleft density changes with combined exercise protocols in an experimental model of muscular hypertrophy

  2021cites this paper
• Dissection, in vivo imaging and analysis of the mouse epitrochleoanconeus muscle

  2021cites this paper
• In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy

  2021cites this paper
• NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease

  2021cites this paper
• Spinal Muscular Atrophy: In the Challenge Lies a Solution.

  2021cites this paper
• Activation of Muscle-Specific Kinase (MuSK) Reduces Neuromuscular Defects in the Delta7 Mouse Model of Spinal Muscular Atrophy (SMA)

  2021cites this paper
• Macrophage roles in peripheral nervous system injury and pathology: Allies in neuromuscular junction recovery.

  2021cites this paper
• A novel CARM1-HuR axis involved in muscle differentiation and plasticity misregulated in spinal muscular atrophy.

  2021cites this paper
• The Neuromuscular Junction: Roles in Aging and Neuromuscular Disease

  2021cites this paper
• Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes.

  2021cites this paper
• Human neuromuscular junction on micro-structured microfluidic devices implemented with a custom micro electrode array (MEA).

  2021cites this paper
• Creating stem cell‐derived neuromuscular junctions in vitro

  2021cites this paper
• The Mouse Levator Auris Longus Muscle: An Amenable Model System to Study the Role of Postsynaptic Proteins to the Maintenance and Regeneration of the Neuromuscular Synapse

  2020cites this paper
• Morphological variability is greater at developing than mature mouse neuromuscular junctions

  2020cites this paper
• LCM-seq reveals unique transcriptional adaptation mechanisms of resistant neurons and identifies protective pathways in spinal muscular atrophy

  2020influential citation
• Post-synaptic morphology of mouse neuromuscular junctions is linked to muscle fibre type

  2020cites this paper
• AAV9-DOK7 gene therapy reduces disease severity in Smn2B/- SMA model mice.

  2020cites this paper
• AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice

  2020cites this paper
• Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle‐specific properties, and the presence of underlying pathology in mice

  2020cites this paper
• Drug treatment for spinal muscular atrophy types II and III.

  2020cites this paper
• Muscle-specific SMN reduction reveals motor neuron-independent disease in spinal muscular atrophy models.

  2020cites this paper
• Reduced TUBA1A Tubulin Causes Defects in Trafficking and Impaired Adult Motor Behavior

  2020cites this paper
• Functional abnormalities of cerebellum and motor cortex in spinal muscular atrophy mice.

  2020cites this paper
• Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy

  2020cites this paper
• Whole-mount staining of neuromuscular junctions in adult mouse diaphragms with a sandwich-like apparatus.

  2020cites this paper
• NMJ-Analyser: high-throughput morphological screening of neuromuscular junctions identifies subtle changes in mouse neuromuscular disease models

  2020cites this paper
• Spinal muscular atrophy — insights and challenges in the treatment era

  2020cites this paper
• SMN Protein Contributes to Skeletal Muscle Cell Maturation Via Caspase-3 and Akt Activation

  2020cites this paper
• How to Build and to Protect the Neuromuscular Junction: The Role of the Glial Cell Line-Derived Neurotrophic Factor

  2020cites this paper
• Spinal Muscular Atrophy: Evidence of a Multi-System Disease

  2020cites this paper
• Effect of chronic intermittent hypoxia (CIH) on neuromuscular junctions and mitochondria in slow- and fast-twitch skeletal muscles of mice—the role of iNOS

  2020cites this paper
• Neuroanatomical Models of Muscle Strength and Relationship to Ambulatory Function in Spinal Muscular Atrophy

  2020cites this paper
• Reduced P53 levels ameliorate neuromuscular junction loss without affecting motor neuron pathology in a mouse model of spinal muscular atrophy

  2019cites this paper
• Implication des cellules gliales dans la modulation de l’activité synaptique à la jonction neuromusculaire sénescente

  2019cites this paper
• Pathologic alterations in the proteome of synaptosomes from a mouse model of spinal muscular atrophy.

  2019cites this paper
• Altered mitochondrial bioenergetics are responsible for the delay in Wallerian degeneration observed in neonatal mice

  2019cites this paper
• Survival Motor Neuron (SMN) Protein Insufficiency Exacerbates Renal Ischemia/Reperfusion Injury

  2019cites this paper
• Muscle fiber-type selective propensity to pathology in the nmd mouse model of SMARD1.

  2019cites this paper
• AAV9-Stathmin1 gene delivery improves disease phenotype in an intermediate mouse model of Spinal Muscular Atrophy.

  2019cites this paper